Cargando…
Cardiac resynchronization therapy is certainly cardiac therapy, but how much resynchronization and how much atrioventricular delay optimization?
Cardiac resynchronization therapy has become a standard therapy for patients who are refractory to optimal medical therapy and fulfill the criteria of QRS >120 ms, ejection fraction <35% and NYHA class II, III or IV. Unless there is some other heretofore unrecognized effect of pacing, the bene...
Autores principales: | Kyriacou, Andreas, Pabari, Punam A., Francis, Darrel P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3474907/ https://www.ncbi.nlm.nih.gov/pubmed/21796453 http://dx.doi.org/10.1007/s10741-011-9271-1 |
Ejemplares similares
-
When is an optimization not an optimization? Evaluation of clinical implications of information content (signal-to-noise ratio) in optimization of cardiac resynchronization therapy, and how to measure and maximize it
por: Pabari, Punam A., et al.
Publicado: (2010) -
Evidence that conflict regarding size of haemodynamic response to interventricular delay optimization of cardiac resynchronization therapy may arise from differences in how atrioventricular delay is kept constant
por: Sohaib, S.M. Afzal, et al.
Publicado: (2015) -
Cardiac resynchronization therapy and AV optimization increase myocardial oxygen consumption, but increase cardiac function more than proportionally()
por: Kyriacou, Andreas, et al.
Publicado: (2014) -
Effect of Interventricular Electrical Delay on Atrioventricular Optimization for Cardiac Resynchronization Therapy
por: Gold, Michael R., et al.
Publicado: (2018) -
Potential benefit of optimizing atrioventricular & interventricular delays in patients with cardiac resynchronization therapy
por: Urbanek, Bozena, et al.
Publicado: (2017)